AIDS activist Tabet dies at 42

------ Original Message ----- 
From: roberta franklin 
To: taoss@worldnet.att.net 
Sent: Tuesday, July 13, 2004 9:25 PM
Subject: A news story from (Roberta Franklin)

This story is being sent to you by Roberta Franklin (firstladytms@aol.com) on Wednesday, July 14, 2004 at 02:25:24
---------------------------------------------------------------------------

http://www.montgomeryadvertiser.com/NEWS/StoryAlabamatabet713w.htm

Click the above link for a news story from The Advertiser

Sherry, this is the article in today's paper about is death. This is strange. He just won a lawsuit against Alabama about it's awful medical care. He was only 42. He testified against the big medical company that was the overseer of Alabama's prison. I will send you another article about the lawsuit in the next article. This is scary. I really believe they got him because of the position he took.

Roberta

Courtesy of The Montgomery Advertiser and Roberta Franklin

AIDS activist Tabet dies at 42 


 Dr. Stephen R. Tabet, an AIDS activist who played a key role in improving prison health care in Alabama and Washington state, is dead of an unknown ailment at age 42. 

 Tabet, an associate professor of medicine at the University of Washington, died at his home July 6. Results from tests to determine the cause of death are expected within six to eight weeks, according to the King County medical examiner's office.

 Over the past year Tabet was a driving force with the HIV Vaccine Trials Network, based in Seattle, in developing a therapy program for people who become infected with HIV as vaccine test subjects. 

 The anti-retroviral therapy will be used at all 32 of the network's vaccine trial sites worldwide, director Dr. Judith Wasserheit said. 

 Tabet grew up in Belen, N.M., worked in his grandfather's store and became interested in medicine at age 18 when his mother died of leukemia. 

 Tabet earned his medical degree as a presidential scholar at the University of New Mexico and a master's degree in public health at the university in Seattle. 

 At McNeil Island Corrections Center he developed a treatment program for inmates with hepatitis C, started a company to treat those with HIV and overhauled the prison clinic after it was shut down for various failings, said Dr.
 Beth Weaver, his successor in that work. 

 A report he produced on the care of HIV-infected inmates led to a landmark court settlement in Alabama last month. 

 --The Associated Press 


Back